Navigation Links
Indian Ayurveda in troubled waters abroad.

Ayurvedic medicines exported from India to Canada have run in troubled waters. An alert has been sounded on 18 types of Ayurvedic medicines by the Canadian government. //

The action has been taken because the samples which were tested contained heavy metals like lead, mercury, arsenic much beyond the permissible limits.

The reason was that most of the medicines did not have labels declaring the presence of those heavy metals. The probe was done by the Canadian government’s health department. The findings are present in Journal of the American Medical Association.

The reason attributed to the presence of these heavy metals in the medicines is pollution of soil and water. The names of the medicines found to contain high content of heavy metals were Mahayogaraj Guggulu with silver and Makardhwaj (Baidyanath), Mahalaxmi Vilas with gold (Baidyanath), Navratna Rasa (Unjha Pharmacy) and Swarna Mahayograj Gugglu with gold (Baidyanath). Products of big companies like Dabur and Zandu are also on the caution list.

It has been mentioned in the Drugs and Cosmetic Rules 1954, prevalent in India, that labels on medicines should mention all the ingredients. As per Rule 161, medicines containing poisonous substances like mercury, arsenic and red oxide of lead have to carry a warning.

In order to pose a solution the government is making mandatory for testing of all herbal medicines, including Ayurvedic, Unani and Siddha from January 1, 2006. Every licensed manufacturer of herbal products in the country will have to declare the content of heavy metals on the containers before exports.


'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
Breaking Medicine Technology:Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3 2410 000 ISSAC Award for Innovation Presented to MIT PhD 13120 1 2410 000 ISSAC Award for Innovation Presented to MIT PhD 13120 2Next Generation Hemostatic Dressing Available for Military Emergencies 52209 1Next Generation Hemostatic Dressing Available for Military Emergencies 52209 2Next Generation Hemostatic Dressing Available for Military Emergencies 52209 3Review of STAARs Application for the Visian 28R 29 Toric Implantable Collamer 28R 29 Lens by FDA to Resume 52205 1Review of STAARs Application for the Visian 28R 29 Toric Implantable Collamer 28R 29 Lens by FDA to Resume 52205 2Review of STAARs Application for the Visian 28R 29 Toric Implantable Collamer 28R 29 Lens by FDA to Resume 52205 3Review of STAARs Application for the Visian 28R 29 Toric Implantable Collamer 28R 29 Lens by FDA to Resume 52205 4Review of STAARs Application for the Visian 28R 29 Toric Implantable Collamer 28R 29 Lens by FDA to Resume 52205 5